Taken together, these data suggest that HFD induces the IRF3, TGFβ1, and STAT3 signaling pathways in AT that in part might suppress the expression of PPAR-γ to maintain low-grade chronic inflammation in AT during HFD-induced obesity. The gene discussed is STAT3; the disease is obesity disorder.